DANIEL G WELCH
CIK 1206199 · Chairman, CEO and President · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.29M
Companies
8
Total Filings
108
Lifetime Open-Market Net
-$34.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RARE | Director | 40,441 | $24.35 | $984.7K | $0 | 13 | 2026-05-18 |
| PRTA | Director | — | $8.25 | — | $0 | 4 | 2026-05-15 |
| GPCR | Director | 123,508 | $42.93 | $5.30M | $0 | 4 | 2025-06-25 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 659,947 | $0.01 | $3.4K | $0 | 6 | 2024-05-29 |
| Seagen Inc. (SGEN) Delisted | Director | 0 | $228.74 | $0 | -$34.84M | 31 | 2023-12-15 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 8,060 | $19.00 | $153.1K | -$102.1K | 8 | 2020-06-01 |
| AveXis, Inc. (AVXS) Delisted | Director | 0 | — | — | $0 | 4 | 2018-05-15 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | Director | 0 | — | — | $0 | 3 | 2015-05-08 |
Recent Filings · Page 5 of 11
108 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-22 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,787 | $0 | EDGAR |
| 2018-06-20 | RARE | Grant (A) | +3,000 | $0 | EDGAR |
| 2018-05-22 | Seagen Inc. (SGEN) Delisted | Grant (A) | +3,700 | $0 | EDGAR |
| 2018-05-15 | AveXis, Inc. (AVXS) Delisted | Disp (D) | +1,106 | $0 | EDGAR |
| 2018-03-30 | AveXis, Inc. (AVXS) Delisted | Grant (A) | +1,106 | $0 | EDGAR |
| 2018-02-15 | Seagen Inc. (SGEN) Delisted | Exer (M) | +16,881 | $158.5K | EDGAR |
| 2017-08-02 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −602 | -$74.6K | EDGAR |
| 2017-07-21 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Sell (S) | −217 | -$27.5K | EDGAR |
| 2017-06-29 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,423 | $0 | EDGAR |
| 2017-06-22 | RARE | Grant (A) | +1,875 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.